Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)

[1] Diamanti-Kandarakis E(2006)Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol Med 12 324-332

[2] Papavassiliou AG(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47

[3] Alvarez-Blasco F(2006)Prevalence and characteristics of the polycystic ovary syndrome in over-weight and obese women Arch Intern Med 166 2081-2086

[4] Botella-Carretero JI(2010)Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan BMC Med 8 41-1143

[5] San Millan JL(1991)Metabolic implications of body fat distribution Diab Care 14 1132-109

[6] Escobar-Morreale HF(2013)The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis Obes Rev 14 95-285

[7] Teede H(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-37

[8] Deeks A(2012)A 2012 clinical update for internists in adult nonalcoholic fatty liver disease Panminerva Med 54 29-247

[9] Moran L(2009)An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome J Gastroenterol Hepatol 24 243-814

[10] Bjorntorp P(2011)Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 801-154

[1] Diamanti-Kandarakis E(2006)Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol Med 12 324-332

[2] Papavassiliou AG(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47

[3] Alvarez-Blasco F(2006)Prevalence and characteristics of the polycystic ovary syndrome in over-weight and obese women Arch Intern Med 166 2081-2086

[4] Botella-Carretero JI(2010)Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan BMC Med 8 41-1143

[5] San Millan JL(1991)Metabolic implications of body fat distribution Diab Care 14 1132-109

[6] Escobar-Morreale HF(2013)The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis Obes Rev 14 95-285

[7] Teede H(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-37

[8] Deeks A(2012)A 2012 clinical update for internists in adult nonalcoholic fatty liver disease Panminerva Med 54 29-247

[9] Moran L(2009)An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome J Gastroenterol Hepatol 24 243-814

[10] Bjorntorp P(2011)Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 801-154